Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Frieling

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
The Lancet. Gastroenterology & Hepatology|October 7, 2022
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomised controlled trialThijs Kuipers, Fraukje A Ponds, Paul Fockens, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 19, 2022
The serotonin receptor 3E variant is a risk factor for female IBS-DNikola Fritz, Sabrina Berens, Yuanjun Dong, et al.
Journal of Cellular and Molecular Medicine|June 24, 2021
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndromeSandra Mohr, Nikola Fritz, Christian Hammer, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
The Lancet. Gastroenterology & Hepatology|October 7, 2022
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomised controlled trialThijs Kuipers, Fraukje A Ponds, Paul Fockens, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 19, 2022
The serotonin receptor 3E variant is a risk factor for female IBS-DNikola Fritz, Sabrina Berens, Yuanjun Dong, et al.
Journal of Cellular and Molecular Medicine|June 24, 2021
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndromeSandra Mohr, Nikola Fritz, Christian Hammer, et al.
Pageof 9